Battelle Memorial Institute Signs on as Development Partner

Columbus, Ohio. The Battelle Memorial Institute’s Heath Care Division has signed on to be the development partner of STATfusion, the infusion system that has captivated home care and prehospital care end-users. The two companies are working to raise capital to fund human factors trials that will eventually be used in the FDA filings.

Intellectual Property Update

(Washington, DC) The US Patent and Trademark Office has allowed LifeMedix’s® second patent for the STATfusion medical infusion system.

(Beijing, China) The Chinese Patent Trademark Office has allowed LifeMedix’s® first US patent into the Chinese patent system.

Two additional patents are pending in the US and  European Patent Office.

Strategic Investor Commits to Additional Investment

(Cleveland, OH) A strategic investor has committed to an additional round of seed B funding. This will allow LifeMedix® to continue to move ahead with our vision of creating a simple, nurse intuitive, rugged, independently powered intravenous infusion system that ranges from bolus to titration rates for prehospital care, air ambulances, special operations, military medics, national disaster preparedness, and others in the first-responder markets.

LifeMedix® Attends EMS World 2013

(Las Vegas, NV) The LifeMedix® team attended the EMS World Conference n Las Vegas, Nevada in September, 2013. The team presented the STATfusion medical infusion system to North America’s largest distributor of prehospital care products, along with potential strategic partners. Again, the team was met with an enthusiastic audience.

LifeMedix® Presents Poster at MHSRS

LifeMedix presents a poster at the Military Health Research Symposium in Ft. Lauderdale, Florida in August, 2013. This was an opportunity to present the STATfusion™ medical resuscitation system to the US and international military community. The device received accolades from military decision makers, regulatory officials and privately held companies.